Document is current
Any future updates will be listed below
-
Authors
Kvasnikov, Boris B. https://orcid.org/0000-0002-0806-7061
Barbarash, Olga L. https://orcid.org/0000-0002-4642-3610
Polikutina, Olga M. https://orcid.org/0000-0001-7458-6962
Burtsev, Yuriy P. https://orcid.org/0000-0002-5379-7258
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05210465 at ClinicalTrials.govDocuments that mention this clinical trial
Trimetazidine's Anti-ischemic Effectiveness in Patients with Stable Angina with Prior Myocardial Infarction Evaluated via Stress Echocardiography with Speckle Tracking: METHOD study
https://doi.org/10.1007/s40119-026-00447-7
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 23 March 2026
First Online: 29 April 2026
Declarations
:
: Olga L. Barbarash declares providing consultancy services, participation in advisory boards, research and speaker activities for Novartis, Sanofi, Servier, and Nizhpharm pharmaceutical companies. Olga M. Polikutina declares no conflict of interest. Boris B. Kvasnikov is an employee of Servier Russia. Yuriy P. Burtsev was by the time of the manuscript development an employee of Servier Russia.
: The study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. The study protocol was approved by the Inter-academic Ethics Committee (Moscow, Russia) on November 25, 2021, protocol #10. Informed consent for medical record review and the use of research-related health information was obtained in accordance with local regulations.
